Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-116-6 | CAS number: 52609-19-5 1 - 2.5 moles ethoxylated
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Ames (OECD 471): not mutagenic in bacteria
Chromosomal Aberration (OECD 473): not clastogenic in mammalian cells
HPRT (OECD 476): not mutagenic in mammalian cells
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
To cover the endpoint genotoxicity of substance C16AE (CAS 52609-19-5), studies from C16-18AE (CAS 68439-49-6) were taken for read-across. Read-across is justified because the length of the alkyl chain and the grade of ethoxylation does not exert any meaningful influence on genotoxicity. Moreover, the structure of alcohol ethoxylates (AE) is not of concern for potential genotoxicity and in all available in-vitro and in-vivo genotoxicity assays, there was no indication of genetic toxicity of a broad range of structurally different AE (HERA, 2009).
Mutagenicity in bacteria was assessed in a study performed according to OECD Guideline 471. Salmonella typhimurium strains TA 1535, TA 1537, TA 98 and TA 100 were treated with C16-18AE (CAS 68439-49-6) using the plate incorporation method as well as the preincubation method, both with and without the addition of a rat liver S9-mix. The dose ranges were for the plate incorporation test were 50, 160, 500, 1600 and 5000 µg/plate; for the first preincubation test 50, 150, 300, 900 and 1500 µg/plate and for the second one 10, 25, 50, 100 and 150 µg/plate. All tests were done in triplicates. The vehicle (acetone) and negative (untreated) control plates produced counts of revertant colonies within an acceptable range. All positive controls used in the test induced marked increases in the frequency of revertant colonies, both with and without the metabolising system. A reproducible mutagenic activity of the test material to any of the tester strains was not observed with and without metabolic activation. Thus, under the conditions of this test the test substance can be regarded as not mutagenic in bacteria.
The clastogenic potential was assessed in a chromosomal aberration test with C16-18AE (CAS 68439-49-6) in mammalian cells according to OECD Guideline 473. Chinese hamster ovary cells (CHO) were exposed to 313, 625, 1250, 2500 and 5000 µg/mL in the presence and 1.25, 2.5, 5, 10, 20, 39 and 78 µg/mL in the absence of metabolic activation. Positive and vehicle (1% ethanol) control cultures were included in each assay. No increases in the number of chromosome aberrations in the presence or absence of metabolic activation were seen at any concentration tested. Appropriate reference mutagens used as positive controls showed a significant increase in chromosome aberrations, thus indicating the sensitivity of the assay, and the efficacy of the S9-mix. Hence, the test substance can not be regarded as clastogenic.
The mutagenic potential in mammalian cells was assessed with C16-18AE (CAS 68439-49-6) by a HPRT-assay according to OECD Guideline 476. Following pre-tests with the concentration ranging from 1-100 µg/mL, the latter being the solubility limit of the test substance, Chinese hamster ovary cells were exposed for 4 h to concentrations of 1.8, 6, 18, 60 and 100 µg/mL in the absence and presence of metabolic activation by rat liver S9-mix. No dose-related increases in mutant colony numbers were obtained in two independent experiments with the test substance in either the presence or absence of S9-mix. Appropriate reference mutagens used as positive controls produced highly significant increases in mutation frequency, thus indicating the sensitivity of the assay. Therefore, the test substance is regarded as not mutagenic in mammalian cells.
In conclusion, C16AE (CAS 52609-19-5) is regarded as non-genotoxic.
Justification for selection of
genetic toxicity endpoint
No study selected as all results were negative.
Justification for classification or non-classification
According to the classification
criteria of Regulation (EC) No. 1272/2008 (CLP) the substance does not
need to be classified for genotoxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
